Skip to main content
Hemostemix Inc. logo

Hemostemix Inc. — Investor Relations & Filings

Ticker · HEM LEI · 984500C65BB0B8159L77 TSXV Professional, scientific and technical activities
Open in API
Filings indexed 212 across all filing types
Latest filing 2025-05-12 Regulatory Filings
Country CA Canada
Listing TSXV HEM

About Hemostemix Inc.

https://hemostemix.com/

Hemostemix Inc. is a clinical-stage biotechnology company specializing in regenerative medicine through the development and commercialization of autologous (patient's own) blood-derived stem cell therapies. The company's lead investigational product is ACP-01 (Angiogenic Precursor Cell treatment), a platform targeting ischemic conditions such as Critical Limb Ischemia (CLI), ischemic cardiomyopathy, and angina. ACP-01 is designed to address unmet medical needs, particularly in patients ineligible for standard revascularization procedures. Phase II clinical data re-examination for "no option" CLI indicated that ACP-01 administration was safe and associated with reduced ulcer size and decreased rates of amputation and death.

Recent filings

Filing Released Lang Actions
Other.pdf
Regulatory Filings Classification · 1% confidence The document is a shareholder mailing request form allowing holders to request Interim and Annual Financial Statements and MD&A by mail. It is not the actual financial report (10-K or IR), nor an investor presentation, proxy statement, or dividend notice. It does not announce a published report (so not RPA) but simply serves as a regulatory form. It does not fit any specific category, so it defaults to the general Regulatory Filings category (RNS).
2025-05-12 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a news release announcing the closing of a non-brokered private placement of USD $336,500 and the issuance of new common shares. This is a direct update on company fundraising and capital structure changes, matching the definition for a Capital/Financing Update (CAP).
2025-05-12 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is Form 52-109FV1 “Certification of Annual Filings” by the CEO of a Canadian venture issuer. It is an attestation of review and fair presentation of the annual filings (AIF, financial statements, MD&A) required under NI 52-109, not the annual report or MD&A itself, nor an earnings release or board change. It is a regulatory‐required certificate with no specific fitting category, so it falls under the fallback “Regulatory Filings” (RNS).
2025-04-29 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV1 “Certification of Annual Filings” for a venture issuer, which is a regulatory certification under Canadian NI 52-109. It is not the actual annual report or MD&A content but rather a standalone certification of those filings by the CFO. This does not match any specific report category (e.g., 10-K, IR, ER) but is a regulatory filing, so it falls under the fallback Regulatory Filings category (RNS).
2025-04-29 English
Annual MD&A - English.pdf
Management Reports Classification · 1% confidence The document is titled “Management’s Discussion and Analysis of the Results of Operations and Financial Condition” for the year ended December 31, 2024 and 2023. It contains a narrative overview of financial results, business trends, forward‐looking statements, and corporate updates typical of an MD&A filing. It is not a short announcement but a full MD&A report. Therefore, it matches the “Management Reports” category (Code: MDA).
2025-04-29 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 1% confidence The document is a completed Form 13-501F1: a regulatory certificate and fee calculation submitted to the Alberta Securities Commission. It is not an annual or quarterly report, earnings release, dividend notice, or other specific corporate action announcement. This is a regulatory filing to a securities regulator and does not neatly fit any specialized category, so it falls under the general “Regulatory Filings” category.
2025-04-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.